Clinical Trials in Melanoma

Published Caitlin Broomhall on

This webinar focused on clinical trials for melanoma, concentrating on patient access to trials and the nursing implications for patients when they are on trials. Nurses gained insights into current clinical trials in Australia for melanoma, and the session explored the specialist nurse's role in caring for patients who are on trials, including providing education about trials, delivering usual care, and communicating with the trial team, so that nurses can support melanoma patients in clinical trials with equitable access and comprehensive care.

Watch on demand

Event recording

Recording guide

Explore the topics

Open the guide below to see the seven topics covered, then select any topic to open the recording at that point on YouTube in a new tab.

Show the 7 topicsHide the topics
01 Welcome and speaker introductions (opens in a new tab) 0:00 → Introduces Maria Gonzalez, Director of Clinical Care at Melanoma Institute Australia, and community representative Dr Michael Armstrong. 02 Why clinical trials matter: the "third space" paradigm (opens in a new tab) 3:14 → Explains why clinical trials remain essential even with many approved treatments, focusing on the roughly 40% of patients who don't respond to standard immunotherapy. 03 Nursing tools: the PICO framework, trial registries and overcoming barriers (opens in a new tab) 12:28 → Introduces a framework for understanding trials, where to find open trials, and the common barriers that keep patients from accessing them. 04 The nurse's role in trial transitions and the future of melanoma trials (opens in a new tab) 20:44 → Covers how nurses support patients starting or leaving a trial, and previews emerging treatments like cell therapy and bispecific T-cell engagers. 05 Patient perspective: Michael's clinical trial journey (opens in a new tab) 27:01 → Introduces community representative Michael Armstrong, who shares his melanoma diagnosis, surgery and decision to join a pivotal adjuvant immunotherapy trial. 06 Reflections on trial design, side effects and the value of advocacy (opens in a new tab) 33:02 → Discusses the trial's design, Michael's treatment side effects, and why he believes every patient needs an advocate. 07 Closing remarks (opens in a new tab) 40:23 → Wraps up the presentation and Q&A session. 

Learning outcomes

What you will learn

After this session, nurses will be able to:

01

Understand the clinical trials landscape

Understand the current landscape of melanoma clinical trials in Australia.

02

Enhance the specialist nurse's role in trial care

Enhance the specialist melanoma nurse's role in trial care.

03

Implement best practices for trial participation

Implement best practices for trial participation and management.

At a glance

The event in brief

Originally held

Tuesday 19 August 2025

Online webinar, part of the Melanoma Nursing Webinar Program.

Who this is for

Nurses

Nurses supporting melanoma patients' access to and participation in clinical trials.

Contributors

Speakers

Maria Gonzalez

Speaker

Maria Gonzalez

Director of Clinical Care, Melanoma Institute Australia

Maria holds dual bachelor's degrees in Nursing and Arts, as well as a Master of Health Science from the University of Sydney. Her clinical career began with nursing roles at Royal Prince Alfred Hospital, Liverpool Hospital and Sydney Private Hospital. Driven by a commitment to advancing cancer treatment, Maria transitioned to clinical research, where she has dedicated 18 years to the field. As Director of Clinical Care at MIA, Maria provides strategic direction, operational oversight and clinical leadership for both nursing and clinical research teams, and is deeply involved in advancing treatments for skin cancer, with a particular focus on neoadjuvant therapy and investigator-driven protocol development. Passionate about enhancing advanced practice nursing within multidisciplinary teams, Maria is a strong advocate for building capacity and ensuring optimal patient outcomes, and is currently working with government and a dedicated team at MIA to develop and implement a Commonwealth-funded national melanoma nurse strategy and program.

Dr Michael Armstrong

Speaker

Dr Michael Armstrong OAM

M.B.B.S. (Syd. Uni.), Community Representative and G.P.

Dr Michael Armstrong is a G.P. on the Northern Beaches of Sydney and has been in full-time practice for over 40 years. For many years he was a Clinical Lecturer in Community Medicine at Sydney University, where he mentored many undergraduates. He has assisted a number of community and medical organisations over a long period of time, and for over 20 years has been Chairman of the Medical Advisory Committee of the Peninsula Private Sleep Laboratory. He currently has an involvement with several committees associated with MIA.

This webinar was brought to you by

Melanoma Institute Logo

Resource details

Man adding substance to inspect underneath a microscope
Course type
Webinars
Duration
40 mins
Price
$0.00
Curriculum Area
Research (incl. Clinical Trials)
Clinical Care
Speciality
Clinician
Nurse
Clinical trials
Melanoma
Nursing
Research

This course is brought to you by

Alliance members